CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 187 filers reported holding CARA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $32,471 | -35.9% | 19,328 | +8.0% | 0.00% | – |
| Q2 2023 | $50,657 | -96.3% | 17,900 | -93.6% | 0.00% | -100.0% |
| Q1 2023 | $1,379,081 | -54.9% | 280,872 | -1.3% | 0.00% | -50.0% |
| Q4 2022 | $3,057,227 | +11.0% | 284,658 | -3.3% | 0.00% | 0.0% |
| Q3 2022 | $2,754,000 | +2.1% | 294,284 | -0.4% | 0.00% | 0.0% |
| Q2 2022 | $2,697,000 | -39.4% | 295,414 | -19.3% | 0.00% | -33.3% |
| Q1 2022 | $4,447,000 | -11.7% | 365,982 | -11.5% | 0.00% | 0.0% |
| Q4 2021 | $5,038,000 | -7.6% | 413,618 | +17.2% | 0.00% | -25.0% |
| Q3 2021 | $5,454,000 | +4.4% | 353,037 | -3.5% | 0.00% | +33.3% |
| Q2 2021 | $5,222,000 | +2210.6% | 365,953 | +3413.4% | 0.00% | – |
| Q1 2021 | $226,000 | +43.0% | 10,416 | -0.1% | 0.00% | – |
| Q4 2020 | $158,000 | – | 10,423 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 2,799,058 | $42,350,000 | 22.29% |
| Chescapmanager LLC | 1,314,603 | $19,890,000 | 2.42% |
| Prosight Management, LP | 294,041 | $4,449,000 | 2.06% |
| DAFNA Capital Management LLC | 261,442 | $3,956,000 | 1.18% |
| Cypress Capital Management LLC (WY) | 81,269 | $1,230,000 | 1.06% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 626,583 | $9,480,000 | 1.02% |
| Carmignac Gestion | 1,851,443 | $28,012,000 | 0.29% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,465,000 | $37,295,000 | 0.22% |
| Ikarian Capital, LLC | 301,700 | $4,565,000 | 0.20% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 689,899 | $10,438,000 | 0.20% |